iGMDRD397
| Standard Name | CHEMBL | Pubchem CID | DRUGBANK ID | Drug Status | Drug Type |
|---|---|---|---|---|---|
| Pazopanib | CHEMBL1201733 CHEMBL477772 | 10114000 | DB06589 | Alone | Small Molecule |
Drug Class:
AmidesAngiogenesis InhibitorsAntineoplastic AgentsAntineoplastic and Immunomodulating AgentsBCRP/ABCG2 SubstratesCytochrome P-450 CYP1A2 SubstratesCytochrome P-450 CYP2D6 InhibitorsCytochrome P-450 CYP2D6 Inhibitors (weak)Cytochrome P-450 CYP3A InhibitorsCytochrome P-450 CYP3A4 InhibitorsCytochrome P-450 CYP3A4 Inhibitors (weak)Cytochrome P-450 Enzyme InhibitorsHeterocyclic CompoundsHeterocyclic Compounds, 1-RingImmunosuppressive AgentsKinase InhibitorModerate Risk QTc-Prolonging AgentsP-glycoprotein/ABCB1 SubstratesProtein Kinase InhibitorsQTc Prolonging AgentsReceptors, Vascular Endothelial Growth Factor, antagonists & inhibitorsSulfonesSulfur CompoundsUGT1A1 InhibitorsDrug Targets:
FLT1 (P17948)KDR (P35968)FLT4 (P35916)PDGFRA (P16234)PDGFRB (P09619)KIT (P10721)FGFR3 (P22607)ITK (Q08881)FGF1 (P05230)SH2B3 (Q9UQQ2)VEGFRCSF1RDrug Pathways:
RTK signalingDrug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
| Gene ID | Gene Name | Model Num. |
|---|---|---|
| 2956 | MSH6 | 1 |
| 8266 | UBL4A | 1 |
| 2475 | MTOR | 3 |
| 6598 | SMARCB1 | 1 |
| 1387 | CREBBP | 1 |
| 5159 | PDGFRB | 1 |
| 25937 | WWTR1 | 1 |
| 3091 | HIF1A | 1 |
| 2034 | EPAS1 | 1 |
| 1665 | DHX15 | 1 |
| 3688 | ITGB1 | 1 |
| 7428 | VHL | 1 |
| 6850 | SYK | 2 |
| 54464 | XRN1 | 1 |
| 92 | ACVR2A | 1 |
| 139285 | AMER1 | 1 |
| 5834 | PYGB | 1 |
| 7157 | TP53 | 1 |
| 3791 | KDR | 1 |
| 2263 | FGFR2 | 2 |
| 4904 | YBX1 | 1 |
| 57111 | RAB25 | 1 |
| 4089 | SMAD4 | 1 |
| 54658 | UGT1A1 | 1 |
| 5290 | PIK3CA | 1 |
| 2113 | ETS1 | 1 |
| 1869 | E2F1 | 2 |
| 5925 | RB1 | 1 |
| 7040 | TGFB1 | 1 |
| 2261 | FGFR3 | 1 |
| 4763 | NF1 | 2 |
Gene in drug-gene network: Network Plot
Models in Pazopanib

